Literature DB >> 7522572

Characterization of an RNase H deficient mutant of human immunodeficiency virus-1 reverse transcriptase having an aspartate to asparagine change at position 498.

J J DeStefano1, W Wu, J Seehra, J McCoy, D Laston, E Albone, P J Fay, R A Bambara.   

Abstract

It has been proposed that Asp-443, Glu-478, and Asp-498 are important in RNase H mediated catalysis by human immunodeficiency virus-1 reverse transcriptase (Davies J.F., Hostomska, Z. Hostomsky, Z., Jordan, S.R. and Matthews, D.A. (1991) Science 251, 88-95; Mizrahi, V., Usdin, M.T., Harington, A. and Dudding, L.R. (1990) Nucleic Acids Res. 18, 5359-5363). Single point mutations at either position 443 (Mizrahi, V., Usdin, M.T., Harington, A. and Dudding, L.R. (1990) Nucleic Acids Res. 18, 5359-5363) or 478 (Schatz, O., Cromme, F.V., Grüninger-Leitch, F. and Le Grice, S.F.J. (1989) FEBS Lett. 257, 311-314) severely inhibit RNase H activity but have only small effects on polymerase activity. We show here that a single mutation at position 498 of Asp to Asn (mutant D498N) results in a stable enzyme with a 20-fold reduction in the ratio of RNase H to polymerase activity. The mutant and wild type enzymes were equally processive, paused in the same locations, and extended primers at the same rate during DNA synthesis on a heteropolymeric RNA template. The rate of elongation on the homopolymeric template poly(rA) was also the same. The results indicate that the mutation does not affect normally measured catalytic parameters of the polymerase function of the enzyme. D498N catalyzed strand transfer synthesis on homopolymeric, but not heteropolymeric templates, indicating that RNase H activity is not required for the former activity, but is for the latter.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522572     DOI: 10.1016/0167-4781(94)90062-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Nonnucleoside reverse transcriptase inhibitor-resistant HIV is stimulated by efavirenz during early stages of infection.

Authors:  Jiong Wang; Gang Zhang; Robert A Bambara; Dongge Li; Hua Liang; Hulin Wu; Hannah M Smith; Nicholas R Lowe; Lisa M Demeter; Carrie Dykes
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

2.  Asymmetric subunit organization of heterodimeric Rous sarcoma virus reverse transcriptase alphabeta: localization of the polymerase and RNase H active sites in the alpha subunit.

Authors:  S Werner; B M Wöhrl
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Pausing during reverse transcription increases the rate of retroviral recombination.

Authors:  Christian Lanciault; James J Champoux
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

4.  RNase H requirements for the second strand transfer reaction of human immunodeficiency virus type 1 reverse transcription.

Authors:  C M Smith; J S Smith; M J Roth
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

5.  Comparison of second-strand transfer requirements and RNase H cleavages catalyzed by human immunodeficiency virus type 1 reverse transcriptase (RT) and E478Q RT.

Authors:  C S Snyder; M J Roth
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Structural Insights into HIV Reverse Transcriptase Mutations Q151M and Q151M Complex That Confer Multinucleoside Drug Resistance.

Authors:  Kalyan Das; Sergio E Martinez; Eddy Arnold
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

7.  Mechanism analysis indicates that recombination events in HIV-1 initiate and complete over short distances, explaining why recombination frequencies are similar in different sections of the genome.

Authors:  Sean T Rigby; April E Rose; Mark N Hanson; Robert A Bambara
Journal:  J Mol Biol       Date:  2009-02-20       Impact factor: 5.469

8.  The role of template-primer in protection of reverse transcriptase from thermal inactivation.

Authors:  Gary F Gerard; R Jason Potter; Michael D Smith; Kim Rosenthal; Gulshan Dhariwal; Jun Lee; Deb K Chatterjee
Journal:  Nucleic Acids Res       Date:  2002-07-15       Impact factor: 16.971

9.  HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism.

Authors:  Kalyan Das; Sergio E Martinez; Joseph D Bauman; Eddy Arnold
Journal:  Nat Struct Mol Biol       Date:  2012-01-22       Impact factor: 15.369

10.  Altered error specificity of RNase H-deficient HIV-1 reverse transcriptases during DNA-dependent DNA synthesis.

Authors:  Mar Álvarez; Verónica Barrioluengo; Raquel N Afonso-Lehmann; Luis Menéndez-Arias
Journal:  Nucleic Acids Res       Date:  2013-02-26       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.